| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017322871 |
| P356 | DOI | 10.1046/J.1525-1497.1999.11188.X |
| P932 | PMC publication ID | 1496761 |
| P698 | PubMed publication ID | 10571719 |
| P5875 | ResearchGate publication ID | 12728961 |
| P2093 | author name string | J P Smith | |
| T R Riley | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Alcohol consumption and mortality among middle-aged and elderly U.S. adults | Q28256034 | ||
| Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
| The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team | Q29619749 | ||
| Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine | Q30857396 | ||
| Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic | Q31043168 | ||
| Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure | Q34303815 | ||
| Prevention of initial variceal hemorrhage | Q35253482 | ||
| Prophylaxis of first variceal bleeding | Q35268890 | ||
| Hepatotoxicity of nonsteroidal anti-inflammatory drugs | Q35537312 | ||
| Prevention and treatment of drug-induced liver disease | Q38562657 | ||
| Effects of Ethanol on the Liver | Q39989086 | ||
| Adult immunizations | Q40383974 | ||
| Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence. | Q40385238 | ||
| Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? | Q40586591 | ||
| Hepatotoxicity of drugs used in the treatment of gastrointestinal disorders. | Q41072475 | ||
| Milk thistle (Silybum marianum) for the therapy of liver disease | Q41703272 | ||
| Patients with alcohol problems | Q41707148 | ||
| Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease | Q42673894 | ||
| Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group | Q42979181 | ||
| Nonalcoholic steatohepatitis: An expanded clinical entity | Q43036189 | ||
| Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. | Q43039574 | ||
| Hepatic resection versus transplantation for hepatocellular carcinoma | Q43946793 | ||
| Measurements of iron status in patients with chronic hepatitis | Q44529932 | ||
| Prognosis and life expectancy in chronic liver disease | Q44636743 | ||
| Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial | Q44763125 | ||
| Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis | Q45756849 | ||
| The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years | Q45787554 | ||
| Fulminant hepatitis A in intravenous drug users with chronic liver disease. | Q45933396 | ||
| Efficacy of a surveillance program for early detection of hepatocellular carcinoma. | Q51013459 | ||
| Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. | Q51574619 | ||
| Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. | Q52582281 | ||
| Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C | Q60364371 | ||
| Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study | Q68097576 | ||
| Fulminant hepatitis A in chronic HBV carrier | Q69989877 | ||
| Iron increases ethanol toxicity in rat liver | Q70590193 | ||
| Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis | Q70681115 | ||
| Hepatitis A vaccine | Q71015879 | ||
| Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study | Q71173357 | ||
| The public's health unprotected. Reversing a decade of underutilization of hepatitis B vaccine | Q71752735 | ||
| Acute type A hepatitis in three patients with chronic HBV infection | Q71791306 | ||
| Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men | Q71923414 | ||
| Response to interferon alpha therapy is influenced by the iron content of the liver | Q72022186 | ||
| Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron | Q72028980 | ||
| Relationship between liver biochemical tests and dietary intake in patients with liver disease | Q72152868 | ||
| Screening of hepatocellular carcinoma in French patients | Q72642807 | ||
| Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q73300419 | ||
| Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q73333197 | ||
| Iron overload in patients with chronic viral hepatitis: how common is it? | Q73595393 | ||
| Screening for hepatocellular carcinoma | Q74027220 | ||
| Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin | Q74578334 | ||
| Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series | Q77225990 | ||
| Spontaneous bacterial peritonitis | Q77496226 | ||
| P433 | issue | 11 | |
| P921 | main subject | chronic liver disease | Q5113984 |
| P304 | page(s) | 699-704 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Journal of General Internal Medicine | Q6295242 |
| P1476 | title | Preventive care in chronic liver disease | |
| P478 | volume | 14 |
| Q36825075 | Bacterial infection-related morbidity and mortality in cirrhosis |
| Q30379953 | Changing common sense: Anti-platelet/coagulation therapy against cirrhosis. |
| Q42346697 | Chronic liver disease |
| Q35084891 | Hepatitis C virus and arthritis |
| Q35628112 | Hepatocellular carcinoma: updates in primary prevention |
| Q93805935 | In Reply |
| Q38442303 | Increased Risk for Malignant Neoplasms Among Patients With Cirrhosis |
| Q37578276 | Limited Knowledge of Acetaminophen in Patients with Liver Disease |
| Q34177707 | Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark |
| Q80045201 | Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease |
| Q37284454 | Patient knowledge about disease self-management in cirrhosis |
| Q36932082 | Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan |
| Q42346428 | Preventative care in chronic liver diseases |
| Q55472303 | Smoking cessation in primary care clinics. |
| Q79122126 | Sonographic evaluation of the anterior liver surface in chronic liver diseases using a 7.5‐MHz annular‐array transducer: Correlation with laparoscopic and histopathologic findings |
Search more.